These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 510371)

  • 1. Heart atrial cholinergic receptor sites show greater affinity towards agonist compared to ventricular sites.
    Wei JW; Sulakhe PV
    Eur J Pharmacol; 1979 Oct; 58(3):349-50. PubMed ID: 510371
    [No Abstract]   [Full Text] [Related]  

  • 2. Differences in affinities of muscarinic acetylcholine receptor antagonists for brain and heart receptors.
    Gibson RE; Rzeszotarski WJ; Eckelman WC; Jagoda EM; Weckstein DJ; Reba RC
    Biochem Pharmacol; 1983 Jun; 32(12):1851-6. PubMed ID: 6882462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the rate of occupancy of receptors by anti-cholinergic drugs.
    Gilani AU
    Biochem Soc Trans; 1990 Apr; 18(2):289-90. PubMed ID: 2379722
    [No Abstract]   [Full Text] [Related]  

  • 4. Pituitary adenylate cyclase-activating polypeptide: localization and differential influence on isolated hearts from rats and guinea pigs.
    Chang Y; Lawson LJ; Hancock JC; Hoover DB
    Regul Pept; 2005 Jul; 129(1-3):139-46. PubMed ID: 15927709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of hypoxia on atrial muscarinic cholinergic receptors and cardiac parasympathetic responsiveness.
    Wolfe BB; Voelkel NF
    Biochem Pharmacol; 1983 Jul; 32(13):1999-2002. PubMed ID: 6870928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunocytochemical studies of M2 muscarinic receptors in guinea pig atria and ventricles using anti-peptide antibodies.
    Zhu L; Wang WZ; Jin XH; Zhao RR; Hjalmarson A; Fu ML
    Blood Press Suppl; 1996; 3():19-21. PubMed ID: 8973762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences between atrial and ventricular energy-supplying enzymes in five mammalian species.
    Bass A; Stejskalová M; Ostádal B; Samánek M
    Physiol Res; 1993; 42(1):1-6. PubMed ID: 8329368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro metabolism of atrial and ventricular myocardium from normal and atropine treated dogs: effect of carbachol.
    Yusuf SM; Gans JH
    Arch Int Pharmacodyn Ther; 1966 Mar; 160(1):204-10. PubMed ID: 5960120
    [No Abstract]   [Full Text] [Related]  

  • 9. A transient state concept of drug receptor interaction.
    Lüllmann H; Ziegler A
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 280(1):1-21. PubMed ID: 4273670
    [No Abstract]   [Full Text] [Related]  

  • 10. The differential effects of a selective kappa-opioid receptor agonist, U50488, in guinea pig heart tissues.
    Hung CF; Li HJ; Chang HH; Lee GA; Su MJ
    Biomed Res Int; 2015; 2015():906039. PubMed ID: 25815340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agonist-antagonist interactions with rat atrial muscarinic cholinergic receptor sites: differential regulation by guanine nucleotides.
    Wei JW; Sulakhe PV
    Eur J Pharmacol; 1979 Sep; 58(1):91-2. PubMed ID: 499339
    [No Abstract]   [Full Text] [Related]  

  • 12. Regional and subcellular distribution of myocardial muscarinic cholinergic receptors.
    Wei JW; Sulakhe PV
    Eur J Pharmacol; 1978 Nov; 52(2):235-8. PubMed ID: 729636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of slaframine by liver microsomes and flavins.
    Spike TE; Aust SD
    Biochem Pharmacol; 1971 Apr; 20(4):721-8. PubMed ID: 4398329
    [No Abstract]   [Full Text] [Related]  

  • 14. [The affinity of m-cholinomimetics for the m-cholinoreceptors in different tissues].
    Muzaffarov DU
    Eksp Klin Farmakol; 2000; 63(1):24-8. PubMed ID: 10763105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xanomeline: a novel muscarinic receptor agonist with functional selectivity for M1 receptors.
    Shannon HE; Bymaster FP; Calligaro DO; Greenwood B; Mitch CH; Sawyer BD; Ward JS; Wong DT; Olesen PH; Sheardown MJ; Swedberg MD; Suzdak PD; Sauerberg P
    J Pharmacol Exp Ther; 1994 Apr; 269(1):271-81. PubMed ID: 7909557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac alpha 1-adrenoceptor densities in different mammalian species.
    Steinfath M; Chen YY; Lavický J; Magnussen O; Nose M; Rosswag S; Schmitz W; Scholz H
    Br J Pharmacol; 1992 Sep; 107(1):185-8. PubMed ID: 1330160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of cardiac calcium regulatory proteins in atrium v ventricle in different species.
    Lüss I; Boknik P; Jones LR; Kirchhefer U; Knapp J; Linck B; Lüss H; Meissner A; Müller FU; Schmitz W; Vahlensieck U; Neumann J
    J Mol Cell Cardiol; 1999 Jun; 31(6):1299-314. PubMed ID: 10371704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inotropic effect of ouabain and its antagonism by dihydroouabain in rat isolated atria and ventricles in relation to specific binding sites.
    Finet M; Godfraind T; Noel F
    Br J Pharmacol; 1983 Dec; 80(4):751-9. PubMed ID: 6571229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcellular distribution of Deslanatoside C-3H in isolated guinea pig hearts. Interaction of other drugs.
    Marzo A; Ghirardi P; Preti A; Lombardo A
    Biochem Pharmacol; 1976 Feb; 25(4):371-6. PubMed ID: 945743
    [No Abstract]   [Full Text] [Related]  

  • 20. Interaction of the neuromuscular blocking drug atracurium with muscarinic acetylcholine receptors.
    Musílková J; Starshinova LA; Shelkovnikov SA; Tucek S
    Physiol Res; 1991; 40(3):293-304. PubMed ID: 1751476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.